Stephen S Whitehead
Inventor
Stats
- 32 US patents issued
- 52 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 32 US Patents Issued
- 52 US Applications Filed
- 235 Total Citation Count
- Jul 19, 2023 Most Recent Filing
- Jul 15, 1997 Earliest Filing
Work History
| Patent Owner | Applications Filed | Year |
|---|---|---|
| THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | 1
1 1 2 6 7 6 2 2 3 4 4 4 8 1 2 2 | 1997
1999 2000 2001 2003 2004 2005 2006 2007 2008 2009 2011 2012 2013 2014 2016 2017 |
| The Government of the United States As Represented by the Department of Health and Human Services | 1
| 2005
|
| The United States of America,as represented by the Secretary, Department of Helath and Human Service | 1
| 2017
|
| The United States Public Health Service As Represented by the Office of Technology | 1
| 2005
|
| Government of the United States of America, as represented by the Secretary, Department Health | 1
| 2009
|
| The United States of America as represented by the Secretary of the Army | 2
1 | 2004
2014 |
Inventor Addresses
| Address | Duration |
|---|---|
| 7 Prairie Rose La., Gaithersburg, MD 20878 | Mar 02, 04 - Mar 02, 04 |
| Bethesda, MD, US | Aug 18, 11 - Jan 21, 25 |
| Gaithersburg, MD | Nov 30, 99 - Jul 20, 06 |
| Gaithersburg, MD, US | Oct 10, 02 - Dec 07, 10 |
| Montgomery Village, MD | May 12, 05 - Dec 16, 08 |
| Montgomery Village, MD, US | Jan 13, 05 - Sep 12, 23 |
| Montgometry Village, MD, US | Jul 07, 05 - Jul 07, 05 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 51 |
| A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 5 |
| C07H: | SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS | 11 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| 12203100 | 2025 | Development of dengue virus vaccine components | 0 |
| 2024/0084,269 | 2024 | DEVELOPMENT OF DENGUE VIRUS VACCINE COMPONENTS | 0 |
| 11753627 | 2023 | Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4 | 0 |
| 11746335 | 2023 | Development of dengue virus vaccine components | 0 |
| 2022/0251,521 | 2022 | DEVELOPMENT OF DENGUE VIRUS VACCINE COMPONENTS | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.